Moderna’s Bancel Dismisses GSK And Sanofi Challenge In mRNA Vaccines
New Entrants Will Find “It’s Much Harder Than They Think”
Bancel doesn't rate GSK and Sanofi's chances in mRNA vaccines, warning they will face IP 'landmines'. • Source: Getty Images 
